rospatt advises pharma clients on IP rights as well as related aspects of regulatory law. Pharmaceutical regulatory law is governed by a large number of complex regulations, and is closely interlinked between national and European provisions. 

We advise clients on whether their communications are in line with the Therapeutic Products Advertising Act. We also have extensive experience in advising clients prior to the market launch of a generic or biosimilar product. In addition, we offer close monitoring of the market through direct access to the relevant data sources, so as to detect listings of infringing products at the earliest possible stage.